|
 |
Table OP2.5
Opioids: Dosage Formulations
|
PURE AGONISTS
|
| Phenanthrenes |
|
|
| Codeine |
PO |
Tablets/Capsules (doses in mg):
Codeine alone 15, 30, 60
Codeine/APAP 15/300, 30/300, 60/300
Codeine/ASA 30/325, 60/325
Liquids:
Codeine alone 15 mg/5 ml
Codeine/APAP 12/120 mg/5 ml
|
IM
IV
SC |
Injection: 30 and 60 mg/ml |
|
Hydrocodone
|
PO |
Tablets/Capsules (doses in mg):
Hydrocodone/APAP 2.5/500, 5/500, 7.5/650, 7.5/750,
10/325, 10/500,
10/650
Hydrocodone/ASA 5/500
Hydrocodone/Ibuprofen 7.5/200
Liquid:
Hydrocodone/APAP 2.5/167 mg/5 ml (7.5/500 mg/15
ml)
|
| Hydromorphone |
PO |
Tablets:
1, 2, 3, 4 and 8 mg
Liquids: 5 mg/5 ml |
IM
IV
SC
IV PCA |
Injection:
1, 2, 4, and 10 mg/ml |
| PR |
Suppositories:
3 mg |
ED
IT |
Check label
for preservative-free formulation for injection. |
| Levorphanol |
PO |
Tablets:
2 mg |
IM
IV
SC |
Injection:
2 mg/ml |
| Morphine |
PO |
IR tablets: 15, 30 mg
CR/SR tablets: 15, 30, 60, 100, 200 mg
Liquids: 10 mg/5 ml, 20 mg/5 ml, 20 mg/1 ml |
IM
IV
SC
IV PCA |
Injection:
0.5, 1, 2, 4, 5, 8, 10, 15, 25, 50 mg/ml
PCA syringes: 1 and 5 mg/ml, 30 ml |
| PR |
Rectal suppositories:
5, 10, 20, 30 mg |
ED
IT |
Preservative-free
injection: 0.5, 1, 10, 15, 25, and 50 mg/ml |
| Oxycodone |
PO |
IR tablets/capsules (doses in mg):
Oxycodone alone 5, 15, 30
Oxycodone/APAP: 2.5/325, 5/325, 5/500, 7.5/500,
10/650
Oxycodone/ASA: 2.25/325, 4.5/325
CR tablets: 10, 20, 40 and 80 mg
Liquids:
Oxycodone alone 5 mg/5 ml, 20 mg/1 ml
Oxycodone/APAP 5/325 mg per 5 ml |
| Oxymorphone |
IM
IV
SC |
Injection: 1 and 1.5 mg/ml |
| PR |
Suppositories:
5 mg |
| Phenylpiperidines |
<
|
|
| Alfentanil |
ED |
Preservative-free Injection: 500
mcg/ml |
| Fentanyl |
IM
IV
IV PCA |
Injection: 50 mcg/ml |
ED
IT |
Check label for preservative-free formulation
for injection. |
| Meperidine |
PO |
Tablets: 50, 100 mg
Liquid: 50 mg/5 ml |
IM
IV
SC
IV PCA |
Injection:
10, 25, 50, 75 & 100 mg/ml |
| ED |
Check label
for preservative-free formulation for injection. |
| Remifentanil |
IV |
Preservative-free injection: 1
mg/ml |
| Sufentanil |
IV
IV PCA |
Injection: 50 mcg/ml |
| ED |
Preservative-free
injection: 50 mcg/ml |
| Diphenylheptanes |
|
|
| Methadone |
PO |
Tablets: 5 & 10mg
Liquids: 5 mg/5ml, 10 mg/5ml, 10 mg/1ml |
IM
IV
SC |
Injection:
10 mg/ml |
| ED |
Check label
for preservative-free formulation for injection. |
| Propoxyphene |
PO |
Tablets/capsules (doses in mg):
Propoxyphene 65, 100
Propoxyphene HCl/APAP 65/650
Propoxyphene Napsylate/APAP 50/325, 100/650
Propoxyphene HCl/ASA/Caffeine 65/389/32.4 |
| MIXED
AGONIST-ANTAGONISTS OPIOIDS |
| Buprenorphine |
IM
IV |
Injection: 0.324 mg (equivalent
to 0.3 mg buprenorphine) / ml |
| Butorphanol |
IM
IV |
Injection: 1 and
2 mg/ml |
| Dezocine |
IM
IV
SC |
Injection: 5, 10, and 15 mg/ml |
| Nalbuphine |
IM
IV
SC |
Injection: 10 and 20 mg/ml |
| Pentazocine |
PO |
Tablets (doses in mg):
Pentazocine/APAP 25/650
Pentazocine/ASA 12.5/325
Pentazocine/Naloxone 50/0.5 |
IM
IV
SC |
Injection:
30 mg/ml |
| Other |
|
|
Tramadol
|
PO |
Tablets: 50 mg |
Agents
shown in bold are listed on the VA National
Formulary (VANF, as of Dec. 2001); agents shown in italic are listed
on the DoD Basic Core Formulary (BCF, as of 15 Nov. 2001);
agents shown in bold italic are
listed on both the VANF and BCF. Check listings for specific formulations
and restrictions.
v1.2
|